Additionally, many exosome-derived tumor markers are widely used in clinical applications.For example, carcinoembryonic antigen (CEA) is significantly increased in digestive tract tumors, lung cancer, and breast cancer, and prostate-specific antigen (PSA) is significantly expressed in prostate cancer.8 Here, CEACAM5 is linked to lung carcinoma.